Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Archives of Psychiatry and Clinical Neuroscience Année : 2023

Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia

Résumé

Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19 and should be prioritized for vaccination. However, impaired decision-making capacities could negatively affect the uptake of COVID-19 vaccination in this population. Capacity to consent to COVID-19 vaccination was assessed in 80 outpatients with schizophrenia. Using the MacArthur Competence Assessment Tool for Treatment, 56.3% of the sample were classified as having diminished capacity to consent to the vaccination. Diminished capacity to consent to COVID-19 vaccination was associated with lower vaccination rates, poorer cognition and higher level of psychotic symptoms. Developing interventions for enhancing informed consent for vaccination is urgent within this population.

Dates et versions

hal-03659454 , version 1 (05-05-2022)

Identifiants

Citer

Stephane Raffard, Sophie Bayard, Margot Eisenblaetter, Philippe Tattard, Jérôme Attal, et al.. Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 2023, 273 (2), pp.511-515. ⟨10.1007/s00406-022-01413-9⟩. ⟨hal-03659454⟩
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More